腹腔镜治疗子宫内膜异位症临床分析

Clinical analysis of endometriosis treated by larparoscope

目的:分析腹腔镜手术联合药物治疗子宫内膜异位症的疗效。方法:回顾性分析415例子宫内膜异位症患者腹腔镜手术治疗后的随访资料。结果:丹那唑组术后半年、1年、2年复发率分别为4.3%,5.7%,18.8%,伴不孕者半年、1年、2年受孕率分别为25.1%,31.5%,42.9%;孕三烯酮组半年、1年、2年复发率分别为5.2%,8.0%,20.6%,伴不孕者半年、1年、2年受孕率分别为17.1%,28.0%,53.6%;中药组半年、1年、2年复发率分别为3.5%,8.3%,26.5%,伴不孕者半年、1年、2年受孕率分别为33.2%,35.0%,59.4%。结论:子宫内膜异位症腹腔镜手术后联合用药可降低复发率,提高受孕率。各药物组在受孕率上差异无显著性。术后半年为最佳受孕时间。

Objective：To analyse the clinical effect of larparescopic surgery combined with medicine treatment in endometriosis. Methods：The clinical data in 415 patients with endometriosis undergoing larparoscopic surgery were analysed retrospectively.Results： The postoperative recurrence rate and pregnancy rate of sterility of the half-year,one-year and two-year were 4.3% ,5.7%, 18.8% and 25.1% ,31.5% ,42.9% respectively in danazol group,5.2% ,8.0% ,20.6% and 17.1% ,28.0% ,53.6% respectively in gestrinone group and 3.5%, 8.3% ,26.5% and 33.2%, 35.0%, 59.4% respectively in chinese medicine group.Conelusion：Larparoscopic surgery combined with medicine treatment for endometriosis can decrease the recurrence rate and improve the pregnancy rate.There is no statistical difference in the pregnancy rate among three groups, the optimal time for pregnancy is half-year after operation.